Results 71 to 80 of about 670 (165)

A Study to Analyse the Significance of Pressure-To-Cornea Index in Pseudoexfoliation Eyes with and without Glaucoma [PDF]

open access: yes, 2017
INTRODUCTION: Normal human central corneal thickness (CCT) varies between a range of 490 μm to 560 μm. Whereas the intraocular pressure (IOP) measured by the gold standard method ‘Goldmann Applanation Tonometry’ is based on the assumption that CCT is ...
Abirami, S
core  

OPTICAL NERVE SEGMENTATION USING THE ACTIVE SHAPE METHOD [PDF]

open access: yes, 2016
The paper deals with the segmentation procedure for optical nerve localization and the consequent determination of geometrical parameters such as optical nerve area, radius and diameter.
Augustynek, Martin   +5 more
core   +1 more source

Anatomical and histomorphometric observations on nerve transfer in the distal forearm for the reconstruction of hand function [PDF]

open access: yes, 2016
In the past century, significant understanding in the field of peripheral nerve surgery has been made with the increasing advances of microsurgical techniques and knowledge of topography of peripheral nerves as well as the cellular and molecular events ...
Lin, Shenyu
core  

The Use of ChatGPT to Assist in Diagnosing Glaucoma Based on Clinical Case Reports. [PDF]

open access: yesOphthalmol Ther, 2023
Delsoz M   +6 more
europepmc   +1 more source

Late-onset Relapse of Aqueous Misdirection after Pars Plana Vitrectomy: Case Report and Literature Review. [PDF]

open access: yesJ Curr Glaucoma Pract, 2023
Halkiadakis I   +5 more
europepmc   +1 more source

Prevention of angle-closure glaucoma: balancing risk and benefit [PDF]

open access: yes, 2022
Azuara-Blanco, Augusto   +9 more
core  

Malignant Glaucoma [PDF]

open access: yes, 2013
Krix-Jachym, Karolina, Rękas, Marek
core   +1 more source

Additional Guidance on the Use of the PRESERFLO™ MicroShunt in the Treatment of Glaucoma: Insights from a Second Delphi Consensus Panel [PDF]

open access: yes
INTRODUCTION: The PRESERFLO™ MicroShunt (PMS) has been proven to significantly lower intraocular pressure (IOP) in patients with glaucoma and has been available for use since 2019.
Abegão Pinto, Luís   +13 more
core  

Home - About - Disclaimer - Privacy